DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) — Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking product, Sparrow Ascent, has received clearance from the U.S. Food and Drug Administration (FDA). Sparrow Ascent is a wearable neurostimulation device designed to provide…Read More
Spark Biomedicals secondgeneration device Sparrow Ascent Receives FDA Clearance for Opioid Withdrawal Relief in Adults
